Clinical Trial: A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477756) titled 'A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients' on March 12.

Brief Summary: The aim of this study was to assess the characteristics, treatment patterns, and clinical outcomes among metastatic castration-resistant prostate cancer (mCRPC) patients in the United States (US) who were treated with lutetium-177 vipivotide tetraxetan (177Lu-PSMA-617) in the real-world setting.

Study Start Date: Sept. 04, 2024

Study Type: OBSERVATIONAL

Condition: Prostate Cancer

Recruitment Status: COMPLETED

Sponsor: Novartis Pharmaceuticals

Published by HT D...